P D Miller
Overview
Explore the profile of P D Miller including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
155
Citations
3845
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Watts N, Hattersley G, Fitzpatrick L, Wang Y, Williams G, Miller P, et al.
Osteoporos Int
. 2020 Jun;
31(8):1603-1605.
PMID: 32533195
The original version of this article, published on 21 March 2019, unfortunately contains some typos in Figs. 2, 3, 4, and Supplemental Fig. 1. The corrected figures are given below.
2.
Watts N, Hattersley G, Fitzpatrick L, Wang Y, Williams G, Miller P, et al.
Osteoporos Int
. 2020 Apr;
31(5):1017-1018.
PMID: 32232508
The original version of this article, published on 21 March 2019, unfortunately contained a mistake.
3.
Levine R, Ganeles J, Wang R, Miller P
Compend Contin Educ Dent
. 2020 Feb;
41(2):92-101.
PMID: 32017587
Gingival augmentation therapy is intended to create a healthy band of attached keratinized tissue to inhibit further gingival recession, facilitate plaque control, and improve patient comfort. Although an effective treatment...
4.
Miller P, Pannacciulli N, Malouf-Sierra J, Singer A, Czerwinski E, Bone H, et al.
Osteoporos Int
. 2019 Nov;
31(1):181-191.
PMID: 31776637
Introduction: We conducted a patient-level pooled analysis of four studies to estimate the efficacy and safety of transitioning to denosumab vs. continuing bisphosphonate treatment in postmenopausal women who previously received...
5.
Bilezikian J, Lin C, Brown J, Wang A, Yin X, Ebeling P, et al.
Osteoporos Int
. 2019 Jun;
30(9):1855-1864.
PMID: 31201481
Introduction: Upper limb (wrist, forearm, and humerus) fractures are a significant burden in osteoporosis, associated with significant morbidity and mortality. Denosumab, a monoclonal antibody against RANK ligand, increases bone mineral...
6.
Watts N, Hattersley G, Fitzpatrick L, Wang Y, Williams G, Miller P, et al.
Osteoporos Int
. 2019 Mar;
30(6):1187-1194.
PMID: 30899994
Purpose: Wrist fractures are common, contribute significantly to morbidity in women with postmenopausal osteoporosis, and occur predominantly at the ultradistal radius, a site rich in trabecular bone. This exploratory analysis...
7.
Miller P, Hattersley G, Lau E, Fitzpatrick L, Harris A, Williams G, et al.
Bone
. 2018 Oct;
120:137-140.
PMID: 30359763
Background: Abaloparatide is a 34-amino acid peptide that selectively binds to the RG conformation of the parathyroid hormone receptor type 1. It was developed for the treatment of women with...
8.
Miller P
Compend Contin Educ Dent
. 2018 Sep;
39(8):514-520.
PMID: 30188152
Published more than three decades ago, the original classification of marginal tissue recession described four classes of recession. For example, in Miller Class III recession, there were different scenarios in...
9.
Godat M, Gruen T, Miller P, Craddock R
Compend Contin Educ Dent
. 2018 Sep;
39(8):533-539.
PMID: 30188146
Excess tissue often exists distal to the upper second molar, creating a pocket in the maxillary tuberosity. When removed from this location, this tissue can serve as an optimal piece...
10.
McClung M, Wagman R, Miller P, Wang A, Lewiecki E
Osteoporos Int
. 2017 Feb;
28(5):1723-1732.
PMID: 28144701
Introduction: This study aimed to understand osteoporosis management strategies during a 1-year observational follow-up after up to 8 years of denosumab treatment in a phase 2 study. Methods: During the...